ALK vs REGN · P/E 18, rev $11.73B vs P/E 14, rev $14.34B
Alaska Air Group Inc (ALK) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Alaska Air Group Inc (ALK) is a airlines company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ALK revenue for 2024-12-31 was $11.73B. Net income was $395.0M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. ALK currently screens at market cap $6.18B and trailing P/E 18.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ALK currently screens at market cap $6.18B and trailing P/E 18.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ALK and REGN stock pages for the full models.
Not investment advice.